The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Interleukin-17A and Keratinocytes in Psoriasis
Open accessAbstract
The excellent clinical efficacy of anti-interleukin 17A (IL-17A) biologics on psoriasis indicates a crucial pathogenic role of IL-17A in this autoinflammatory skin disease. IL-17A accelerates the proliferation of epidermal keratinocytes. Keratinocytes produce a myriad of antimicrobial peptides and chemokines, such as CXCL1, CXCL2, CXCL8, and CCL20. Antimicrobial peptides enhance skin inflammation. IL-17A is capable of upregulating the production of these chemokines and antimicrobial peptides in keratinocytes. CXCL1, CXCL2, and CXCL8 recruit neutrophils and CCL20 chemoattracts IL-17A-producing CCR6+ immune cells, which further contributes to forming an IL-17A-rich milieu. This feed-forward pathogenic process results in characteristic histopathological features, such as epidermal hyperproliferation, intraepidermal neutrophilic microabscess, and dermal CCR6+ cell infiltration. In this review, we focus on IL-17A and keratinocyte interaction regarding psoriasis pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–215 of 215
Tsuruta, N., NARISAWA, Y., Imafuku, S., Ito, K., Yamaguchi, K., Miyagi, T., Takahashi, K., Fukamatsu, H., Morizane, S., Koketsu, H., et al. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14745 · Cited by 17
Self-citationChiu, H., Chang, W., Shiu, M., Huang, W., & Tsai, T. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14654 · Cited by 16
Gradual development of psoriatic skin lesions by constitutive low-level expression of IL-17A
Wohn, C., Brand, A., van Ettinger, K., Brouwers-Haspels, I., Waisman, A., Laman, J. D., & Clausen, B. E. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.11.006 · Cited by 14
Momose, M., Asahina, A., Fukuda, T., Sakuma, T., Umezawa, Y., & Nakagawa, H. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14618 · Cited by 14
Meephansan, J., Subpayasarn, U., Ponnikorn, S., Chakkavittumrong, P., Juntongjin, P., Komine, M., Ohtsuki, M., & Poovorawan, Y. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14009 · Cited by 13
Miyoshi, K., Takaishi, M., DiGiovanni, J., & Sano, S. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.10.001 · Cited by 11
Late‐onset psoriatic arthritis in Japanese patients
Yamamoto, T., Ohtsuki, M., Sano, S., Morita, A., Igarashi, A., Okuyama, R., & Kawada, A. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14752 · Cited by 11
Takahashi, H., Satoh, K., Takagi, A., & Iizuka, H. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14876 · Cited by 11
New onset of psoriasis during nivolumab treatment for lung cancer
Chujo, S., Asahina, A., Itoh, Y., Kobayashi, K., Sueki, H., Ishiji, T., Umezawa, Y., & Nakagawa, H. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14167 · Cited by 10
Prevalence of inflammatory bowel disease in Japanese psoriatic patients
Masaki, S., Bayaraa, B., & Imafuku, S. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14900 · Cited by 10
Shiga, T., Sato, K., Kataoka, S., & Sano, S. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.11.008 · Cited by 9
Yamazaki, F., Takehana, K., Tamashima, M., & Okamoto, H. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14545 · Cited by 8
Komatsu‐Fujii, T., Honda, T., Otsuka, A., & Kabashima, K. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14700 · Cited by 5
Psoriasis vulgaris associated with systemic lupus erythematosus successfully treated with apremilast
Ichiyama, S., Hoashi, T., Kanda, N., Hashimoto, H., Matsushita, M., Nozawa, K., Ueno, T., & Saeki, H. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14728 · Cited by 4
Komatsu‐Fujii, T., Honda, T., Otsuka, A., & Kabashima, K. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.15006 · Cited by 3
Cited by
Advances in the pathogenesis of psoriasis: from keratinocyte perspective
Zhou, X., Chen, Y., Cui, L., Shi, Y., & Guo, C. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04523-3 · Cited by 632
Signaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 427
Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin
Jiang, Y., Tsoi, L. C., Billi, A. C., Ward, N. L., Harms, P. W., Zeng, C., Maverakis, E., Kahlenberg, J. M., & Gudjonsson, J. E. (2020) · JCI Insight · doi:10.1172/jci.insight.142067 · Cited by 348
Current Concepts of Psoriasis Immunopathogenesis
Vičić, M., Kaštelan, M., Brajac, I., Sotošek, V., & Massari, L. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111574 · Cited by 163
Tsuji, G., Yamamura, K., Kawamura, K., Kido-Nakahara, M., Ito, T., & Nakahara, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914633 · Cited by 21
Self-citation
Metadata
- Authors
- Furue, M., Furue, K., Tsuji, G., & Nakahara, T.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-13
- Volume
- 21
- Issue
- 4
- Pages
- 1275
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3006622277
- Cited by
- 300
- References
- 215
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.